Davin Talamo-Bromberg’s Post

💊 The cost of drugs has a significant impact on society and the health of patients worldwide. Therefore, research and production of new therapies must necessarily move in the direction of cost reduction 📉 Everyone has the right to access affordable medicines. At the same time, health systems must remain financially sustainable. ➡️ Cellex and its bioreactors will accelerate and lower drug production costs, making every therapy truly affordable and democratic. For everyone.

#Cystatin_C_Assay Market is flourishing because of an increasing focus on the #diagnosis, #treatment, and #management of rising prevalence of renal diseases and #growing #awareness about kidney #health. 🌐𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐭𝐨 𝐁𝐥𝐮𝐞𝐖𝐞𝐚𝐯𝐞 𝐅𝐨𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 𝐨𝐟 "𝐂𝐲𝐬𝐭𝐚𝐭𝐢𝐧 𝐂 𝐀𝐬𝐬𝐚𝐲 𝐌𝐚𝐫𝐤𝐞𝐭" ➖ https://lnkd.in/gAdzHtaj ▶ 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: ✔Abbott,  ✔Sysmex Corporation,  ✔Siemens Healthineers,  ✔RANDOX LABORATORIES LIMITED,  ✔DiaSys Diagnostics India Pvt Ltd  ✔Roche Diagnostics India, Neighbouring Markets,  ✔FUJIFILM Wako Chemicals USA,  ✔Thermo Fisher Scientific, ✔bioMérieux, and ✔abcam. 📢𝐌𝐚𝐫𝐤𝐞𝐭 - 𝐁𝐲 𝐑𝐞𝐠𝐢𝐨𝐧: North America, Europe, Asia Pacific (#APAC), Latin America, and Middle East and Africa. North America dominates the Global #Cystatin_C_Assay_Market owing to rising healthcare #expenditure, #BlueWeave #Consulting #marketresearch #healthacare  #healthcareinnovation 

The Global #Apheresis_Market, which surged from US$ 3,029.2 million in 2022 to a projected #valuation of US$ 6,551.3 million by 2031, boasting a robust #CAGR of 8.7% during the #forecast period 2023–2031. This #growth trajectory is fueled by various factors, including the escalating demand for plasma-derived products, #advancements in apheresis #technologies, and the mounting prevalence of #chronic diseases worldwide. 𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐎𝐮𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐅𝐫𝐞𝐞: https://lnkd.in/gAEw6_Fz A key driver #propelling this expansion is the increasing #demand for plasma-derived products, #constituting approximately 60% of the total apheresis market in 2022. With the global #geriatric population projected to reach 1.5 billion by 2050 and #healthcare expenditure #soaring to $8.7 trillion in 2020. Amidst fierce competition among #multinational and regional players, the top five companies command around 55% of the market #share, driving #innovation through substantial investments in research and development. Recent advancements in #automation, data analysis, and integration with #EHR systems are reshaping the industry landscape, ushering in a new era of #efficiency and #efficacy. 𝐓𝐨𝐩 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐆𝐥𝐨𝐛𝐚𝐥 𝐀𝐩𝐡𝐞𝐫𝐞𝐬𝐢𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 Asahi Kasei Medical America Inc. BKK B. Braun Melsungen AG Baxter International Inc. Cerus Charles River Laboratories Clinical Services International Ltd Haemonetics KANEKA CORPORATION Kawasumi Laboratories Inc (7703) NIKKISO UK CO., LTD. Terumo Blood and Cell Technologies #ApheresisMarket #HealthcareInnovation #PlasmaDerivedProducts #ChronicDiseases #MedicalAdvancements #ResearchAndDevelopment #GeriatricHealth #HealthcareTrends #GlobalHealth #Biotechnology #InnovationInHealthcare 

#Fluid_Waste_Disposal_System Market Insights, Trends & Future Development Status Recorded during 2023-2032 >> https://lnkd.in/dqkpTQdy #Fluid #Waste #Disposal #System Market 2023 research #report gives emerging industry #data, global #segments and regional outlook. This report covers up all details such as #size, share, #value, #growth, restraints, and #opportunities for the year 2023 to 2032. The report generated using various #analysis tools like porter’s five forces #model, #market #attractiveness and value chain. Zimmer Biomet, Fresenius Medical Care, Baxter International Inc., B. BRAUN HOLDING GMBH & CO. KG,, Ecolab, Cardinal Health, BioMedical Waste Solutions #fluidwaste #disposalsystem #researchreport #medicaldevices #medicaltechnologies #healthcareindustry #medicalscience

𝗣𝗼𝗶𝗻𝘁-𝗼𝗳-𝗰𝗮𝗿𝗲 𝗧𝗲𝘀𝘁𝗶𝗻𝗴 (𝗣𝗢𝗖𝗧) 𝗳𝗼𝗿 𝗖𝗵𝗿𝗼𝗻𝗶𝗰 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟰-𝟮𝟬𝟯𝟬. 𝗚𝗹𝗼𝗯𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 The report offers a comprehensive overview of the Point-of-care Testing (POCT) for Chronic Disease industry chain, encompassing the market status of Hospital and Independent Testing Organizations based on Immunochromatography and Chemiluminescence Technology. It provides a detailed analysis of key enterprises in both developed and developing markets, examining cutting-edge technology, patents, hot applications, and market trends within the Point-of-care Testing (POCT) for Chronic Disease sector. Regionally, North America and Europe are experiencing stable growth due to government initiatives and increased consumer awareness, while Asia-Pacific, led by China, dominates the global market with robust domestic demand, supportive policies, and a strong manufacturing base. The report delivers a holistic understanding of the Point-of-care Testing (POCT) for Chronic Disease market, addressing market dynamics, trends, challenges, and opportunities for stakeholders in the industry. 𝗧𝗼 𝗞𝗻𝗼𝘄 𝗗𝗲𝗺𝗮𝗻𝗱 𝗼𝗳 𝗣𝗼𝗶𝗻𝘁-𝗼𝗳-𝗰𝗮𝗿𝗲 𝗧𝗲𝘀𝘁𝗶𝗻𝗴 (𝗣𝗢𝗖𝗧) 𝗳𝗼𝗿 𝗖𝗵𝗿𝗼𝗻𝗶𝗰 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 𝗠𝗮𝗿𝗸𝗲𝘁. 𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗦𝗮𝗺𝗽𝗹𝗲 𝗣𝗗𝗙: https://lnkd.in/d83UdC29 *𝗕𝘆 𝗧𝘆𝗽𝗲: Based on Immunochromatography, Based on Chemiluminescence Technology, Based on Biosensor, Others *𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻: Hospital, independent Testing Organization *𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻: North America, Europe, Asia-Pacific, South America, Middle East & Africa *𝗕𝘆 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: Abbott, bioMérieux, Siemens Healthineers, Roche, Danaher Corporation, Sinocare Inc., Assure Tech, Bio-Rad Laboratories, Guangzhou Wondfo Biotech Co., Ltd, Wuhan Easy diagnosis Biomedicine Co.,LTD #POCT #ChronicDiseaseTesting #HealthcareTech #MedicalInnovation #Immunochromatography #ChemiluminescenceTechnology #MarketAnalysis #HealthcareIndustry #POCTMarketTrends #GlobalHealth #DiagnosticTechnology

Medical Tubing Market to Hit USD 19.7 billion by 2031, at a CAGR 8.1% | Says Transparency Market Research, Inc.: A growing number of chronic diseases and regulatory compliance will drive demand for medical tubing. Advances in technology and the development of new materials will contribute to the growth of the medical tubing market. WILMINGTON, Del., Jan. 4, 2024 /PRNewswire/ -- The medical tubing...

🌍 Explore the Booming Global Bronchitis Treatment Market! 💊 With a valuation of USD 5.73 billion in 2022 and a projected growth rate of 5.37% through 2028, the market is abuzz with opportunities. From targeted therapies to innovative drug repurposing, advancements are reshaping bronchitis treatment. 📈 Dive into our comprehensive insights to uncover the trends, challenges, and regional dynamics driving this dynamic market. Click here to download the sample report: https://lnkd.in/gQ6wEEEp TechSci Research Alwin Samuel Srishti Verma Parvati Sharma

When was the last time you read a whitepaper? Here's one we worked on for Cavenagh Health to add to your reading list 👇 For many companies, whitepapers are a valuable resource – allowing them to take an in-depth exploration into a specific topic. Specialist Life Science recruitment partner, Cavenagh Health, recently released their latest whitepaper ‘Beyond antibiotics: The reckoning of Antimicrobial Resistance - A new biological frontier’ in collaboration with INCATEurope and a consortium of esteemed industry experts, to spotlight the urgent collective effort needed against AMR. To help them call scientists, investors, entrepreneurs, and patients to action, our team designed and supported the development of their 70-page whitepaper. As a result, Cavenagh raised awareness of the scientific, commercial and regulatory challenges in combating AMR for over 1400 people across the biotech, life science and investor communities globally. Have a read of Cavenagh’s whitepaper:  https://lnkd.in/eCfNmhEj Have a topic you’d like to explore in more depth? Contact us to learn how we can support you: https://lnkd.in/em5rjyCE #SomXDesign #AMR #LifeSciences #Healthtech

Drugs that accelerate osteoporosis and sarcopenia are also making Novo Nordisk more money than the entire rest of the economy of Denmark. That kind of wealth buys a lot of influence with medical researchers. First step: Preserve your own health. #WomensHealth #HeathAtEverySize

The global drug discovery market, valued at $58.19 billion in 2021, is expected to grow at a 7.9% CAGR, reaching $113.37 billion by 2030. Factors like rising chronic disease cases, healthcare expenditure, and R&D investments drive this growth. #drugdiscovery #healthcare #research #marketgrowth #InformaConnectAcademy